The 2020 revision of the guidelines for the management of myeloproliferative neoplasms

In 2016, the World Health Organization revised the diagnostic criteria for myeloproliferative neoplasms (MPNs) based on the discovery of disease-driving genetic aberrations and extensive analysis of the clinical characteristics of patients with MPNs. Recent studies have suggested that additional som...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Korean J Intern Med
Autors principals: Kim, Sung-Yong, Bae, Sung Hwa, Bang, Soo-Mee, Eom, Ki-Seong, Hong, Junshik, Jang, Seongsoo, Jung, Chul Won, Kim, Hee-Jin, Kim, Ho Young, Kim, Min Kyoung, Kim, Soo-Jeong, Mun, Yeung-Chul, Nam, Seung-Hyun, Park, Jinny, Won, Jong-Ho, Choi, Chul Won
Format: Artigo
Idioma:Inglês
Publicat: Korean Association of Internal Medicine 2021
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7820646/
https://ncbi.nlm.nih.gov/pubmed/33147902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2020.319
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars